General Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
11/08/17Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in November 2017Printer Friendly Version
11/07/17U.S. FDA Approves Auryxia® (ferric citrate) Tablets as a Treatment for People with Iron Deficiency Anemia and Chronic Kidney Disease, Not on DialysisPrinter Friendly Version
11/07/17Keryx Biopharmaceuticals Announces Third Quarter 2017 Financial Results   Printer Friendly Version
11/06/17Keryx Biopharmaceuticals Moves Third Quarter 2017 Financial Results Call to Tuesday, November 7, 2017 at 8:00 a.m. ETPrinter Friendly Version
11/04/17Keryx Biopharmaceuticals Announces Presentation of Real World Dialysis Data of Auryxia® at ASN’s 2017 Kidney WeekPrinter Friendly Version
11/02/17Keryx Biopharmaceuticals Announces Presentation of Post-Hoc Data From Phase 3 Study of Auryxia® (Ferric Citrate) in Adults With Iron Deficiency Anemia and Non-dialysis Dependent Chronic Kidney DiseasePrinter Friendly Version
10/26/17Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2017 Financial Results on Monday, November 6, 2017Printer Friendly Version
10/13/17Keryx Biopharmaceuticals Announces Presentations of New Data at the American Society of Nephrology Kidney Week 2017 Annual MeetingPrinter Friendly Version
09/13/17Keryx Biopharmaceuticals Announces Changes to its Board of DirectorsPrinter Friendly Version
09/05/17Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in September 2017Printer Friendly Version
08/04/17Keryx Biopharmaceuticals to Webcast its Presentation at Canaccord Genuity’s 37th Annual Growth Conference on August 9, 2017Printer Friendly Version
07/27/17Keryx Biopharmaceuticals Announces Second Quarter 2017 Financial Results and Increased 2017 U.S. Product Sales GuidancePrinter Friendly Version
07/19/17Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2017 Financial Results on Thursday, July 27, 2017Printer Friendly Version
05/30/17Keryx Biopharmaceuticals to Webcast its Presentation at Jefferies’ 2017 Healthcare Conference on June 6, 2017Printer Friendly Version
05/04/17Keryx Biopharmaceuticals Announces First Quarter 2017 Financial ResultsPrinter Friendly Version
05/01/17Keryx Announces that Auryxia® (Ferric Citrate) is Now on Formulary at All Major Medicare Part D PlansPrinter Friendly Version
04/18/17Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2017 Financial Results on Thursday, May 4, 2017Printer Friendly Version
03/20/17Keryx Announces the Largest Medicare Part D Plan Sponsor Added Auryxia® to its Medicare Part D Plan FormulariesPrinter Friendly Version
03/08/17Keryx Biopharmaceuticals Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for Auryxia® (ferric citrate) TabletsPrinter Friendly Version
03/01/17Keryx Biopharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial ResultsPrinter Friendly Version
02/23/17Keryx Biopharmaceuticals to Webcast its Presentations at Two Investor Conferences in March 2017Printer Friendly Version
02/16/17Keryx Biopharmaceuticals to Host Conference Call of Fourth Quarter and Full Year 2016 Financial Results on Wednesday, March 1, 2017Printer Friendly Version
02/08/17Keryx Biopharmaceuticals to Webcast its Presentation at RBC Capital Markets' 2017 Global Healthcare Conference on February 22, 2017Printer Friendly Version
01/12/17Keryx Biopharmaceuticals Announces Publication of Auryxia® (ferric citrate) Phase 3 Trial Results for Iron Deficiency Anemia (IDA) in Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) in Journal of the American Society of NephrologyPrinter Friendly Version
01/08/17Keryx Biopharmaceuticals Announces Recent Business Progress and Reviews Corporate Strategy at 35th Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version